Lv11
76 积分 2025-06-12 加入
Enterocolitis due to immune checkpoint inhibitors: a systematic review
4天前
已完结
Management of Patients With Immune Checkpoint Inhibitor-Induced Enterocolitis: A Systematic Review
4天前
已完结
MA11.04 First-in-Class PD-1/IL-2 Bispecific Antibody IBI363 In Patients with Advanced Non-Small Cell Lung Cancer in a Phase I Study
7天前
已完结
Improving outcomes of patients with pancreatic cancer
8天前
已完结
Therapeutic developments in pancreatic cancer
8天前
已完结
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
12天前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
12天前
已完结
Epidemiology and Clinical Manifestations of Mucormycosis
13天前
已完结
Sintilimab: First Global Approval
13天前
已完结
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
14天前
已完结
皖公网安备34019202002308
